Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET

NCT05336695 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05336695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05336695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 29, 2022
Completion date
September 28, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia of alzheimer type